La’Ron Browne: Balancing Clinical Benefits and Healthcare Costs in Hydroxyurea Management of SCD in Brazil
La’Ron Browne, Instructor at St. Jude Children’s Research Hospital, shared on LinkedIn about a recent article she and her colleagues co-authored, published in Blood Global Hematology, adding:
”I am pleased to announce that our paper on Hydroxyurea therapy in Sickle Cell Disease (SCD): Evaluating healthcare costs and use in a Brazilian tertiary setting has been shortlisted by Blood Global Hematology for impactful manuscripts.
In our study, we highlight that while hydroxyurea (HU) decreased acute utilization in patients with SCD, it did not reduce overall healthcare costs.
The likely drivers of the total health costs were persistent chronic care management, decreased adherence, and later initiation of hydroxyurea.
These findings are important for many low- and middle-income countries (LMIC) and upper-middle-income countries (UMIC) to initiate conversations about implementing hydroxyurea early in life, which can help mitigate the long-standing costs associated with chronic diseases like SCD.”
Title: Hydroxyurea therapy in sickle cell disease: evaluating health care costs and use in a Brazilian tertiary setting
Authors: La’Ron L. A. Browne, Emilia Matos do Nascimento, Patricia Moura, Delaine Fidlarczyk, Jane Duran, Roberto Barbosa, Thais Oliveira, George Goshua, Jane S. Hankins, Clarisse Lobo

Stay updated on all scientific advances with Hemostasis Today.
-
Oct 19, 2026, 08:20Cory Dugan: The IRONWOMAN Trial Individual Responses to IV Iron Therapy in Active Women
-
Oct 19, 2026, 07:36Johannes Kaesmacher: Cerebral No-Reflow After Thrombectomy Toward a Standardized Definition
-
Oct 19, 2026, 07:33Beth Psaila: Highlights from IACH Annual Meeting and MPN Horizons
-
Oct 19, 2026, 07:29Wolfgang Miesbach: Can Losartan Activate Brown Fat? – Nature Study Explores New Therapeutic Link
-
Oct 19, 2026, 07:22Ruben Mesa: Honored to Speak at the Tandem MPN Meetings of IACH
-
Oct 19, 2026, 07:19Saneha Anjum Shaikh: Parul University Partners with Raktasevak Bike Ride 2026 for Blood Donation Drive
-
Oct 19, 2026, 07:09Alejandro González Veliz: No ST Elevation Does Not Guarantee an Open Coronary Artery
-
Oct 19, 2026, 06:02Thomas Dayspring: Vascular Resilience – What Is It and How Can We Measure It?
-
Oct 19, 2026, 05:53Kevon Dindial: Collaboration for Better Childhood Cancer Outcomes